Acquisition by Van Houten Frans of 8820 shares of Absci Corp subject to Rule 16b-3
| ABSI Stock | USD 3.26 0.55 20.30% |
Under 55% of Absci Corp's traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Absci Corp suggests that some traders are interested. Absci Corp's investing sentiment shows overall attitude of investors towards Absci Corp.
Absci |
Filed transaction by Absci Corp Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at benzinga.com
 |
Absci Corp Fundamental Analysis
We analyze Absci Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Absci Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Absci Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Absci Corp is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Absci Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Absci Corp stock to make a market-neutral strategy. Peer analysis of Absci Corp could also be used in its relative valuation, which is a method of valuing Absci Corp by comparing valuation metrics with similar companies.
Peers
Absci Corp Related Equities
| HEPA | Hepion Pharmaceuticals | 30.61 | ||||
| ELEV | Elevation Oncology | 10.00 | ||||
| ZURA | Zura Bio | 9.79 | ||||
| RXRX | Recursion Pharmaceuticals | 8.18 | ||||
| INZY | Inozyme Pharma | 7.72 | ||||
| SANA | Sana Biotechnology | 3.64 | ||||
| RLAY | Relay Therapeutics | 2.79 | ||||
| ABOS | Acumen Pharmaceuticals | 2.70 | ||||
| CRBU | Caribou Biosciences | 2.38 | ||||
| DTIL | Precision BioSciences | 1.28 | ||||
| AFMD | Affimed NV | 0.74 | ||||
| DAWN | Day One | 0.94 | ||||
| XFOR | X4 Pharmaceuticals | 1.33 |
Complementary Tools for Absci Stock analysis
When running Absci Corp's price analysis, check to measure Absci Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Absci Corp is operating at the current time. Most of Absci Corp's value examination focuses on studying past and present price action to predict the probability of Absci Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Absci Corp's price. Additionally, you may evaluate how the addition of Absci Corp to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |